Symptomatic spontaneous intracranial carotid artery dissection treated with a self-expanding intracranial nitinol stent

a case report

Daniel L Surdell, Richard A. Bernstein, Ziad A. Hage, H. Hunt Batjer, Bernard R. Bendok

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Although extracranial carotid dissection with stroke is common, intracranial dissection with stroke is rare. Stenting has been used to treat extracranial carotid dissections. Intracranially, however, it is only recently that stents have become a feasible option for this disease. We present a case of a spontaneous intracranial CAD with progressive symptoms despite medical management treated with a self-expanding intracranial micronitinol stent. Case Description: A 47-year-old, right-handed woman presented to the emergency department after noticing left-sided face and arm weakness and numbness, along with slurred speech. The patient was started on aspirin 325 mg/d orally and lovenox 40 mg/d subcutaneously. On hospital day 2, the patient was noted to have repeated episodes of weakness and numbness on the left side and MRI evidence of a new stroke. A diagnostic cerebral angiogram from a selective right internal carotid injection revealed a flow-limiting stenosis secondary to a dissection of the supraclinoid internal carotid artery with severe flow limitation to the hemisphere. Endovascular management was decided on, and a Neuroform stent measuring 4.5 × 20 mm (Boston Scientific Corporation, Natick, Mass) was deployed across the dissection with significant improvement of flow to that hemisphere on the poststent angiogram. Conclusions: This case illustrates the successful off-label use of a self-expanding intracranial nitinol stent to treat a symptomatic intracranial internal CAD in the setting of failure of traditional medical management. This is a promising application of novel endovascular technology.

Original languageEnglish (US)
Pages (from-to)604-609
Number of pages6
JournalSurgical neurology
Volume71
Issue number5
DOIs
StatePublished - May 1 2009

Fingerprint

Carotid Arteries
Stents
Dissection
Hypesthesia
Stroke
Angiography
Internal Carotid Artery Dissection
Off-Label Use
Enoxaparin
Women's Rights
Aspirin
Hospital Emergency Service
Pathologic Constriction
Arm
Technology
Injections
nitinol

Keywords

  • Intracranial dissection
  • Intracranial stent
  • Spontaneous dissection

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Symptomatic spontaneous intracranial carotid artery dissection treated with a self-expanding intracranial nitinol stent : a case report. / Surdell, Daniel L; Bernstein, Richard A.; Hage, Ziad A.; Batjer, H. Hunt; Bendok, Bernard R.

In: Surgical neurology, Vol. 71, No. 5, 01.05.2009, p. 604-609.

Research output: Contribution to journalArticle

Surdell, Daniel L ; Bernstein, Richard A. ; Hage, Ziad A. ; Batjer, H. Hunt ; Bendok, Bernard R. / Symptomatic spontaneous intracranial carotid artery dissection treated with a self-expanding intracranial nitinol stent : a case report. In: Surgical neurology. 2009 ; Vol. 71, No. 5. pp. 604-609.
@article{a1a52e40259f4d7b91dd986b499df1b4,
title = "Symptomatic spontaneous intracranial carotid artery dissection treated with a self-expanding intracranial nitinol stent: a case report",
abstract = "Background: Although extracranial carotid dissection with stroke is common, intracranial dissection with stroke is rare. Stenting has been used to treat extracranial carotid dissections. Intracranially, however, it is only recently that stents have become a feasible option for this disease. We present a case of a spontaneous intracranial CAD with progressive symptoms despite medical management treated with a self-expanding intracranial micronitinol stent. Case Description: A 47-year-old, right-handed woman presented to the emergency department after noticing left-sided face and arm weakness and numbness, along with slurred speech. The patient was started on aspirin 325 mg/d orally and lovenox 40 mg/d subcutaneously. On hospital day 2, the patient was noted to have repeated episodes of weakness and numbness on the left side and MRI evidence of a new stroke. A diagnostic cerebral angiogram from a selective right internal carotid injection revealed a flow-limiting stenosis secondary to a dissection of the supraclinoid internal carotid artery with severe flow limitation to the hemisphere. Endovascular management was decided on, and a Neuroform stent measuring 4.5 × 20 mm (Boston Scientific Corporation, Natick, Mass) was deployed across the dissection with significant improvement of flow to that hemisphere on the poststent angiogram. Conclusions: This case illustrates the successful off-label use of a self-expanding intracranial nitinol stent to treat a symptomatic intracranial internal CAD in the setting of failure of traditional medical management. This is a promising application of novel endovascular technology.",
keywords = "Intracranial dissection, Intracranial stent, Spontaneous dissection",
author = "Surdell, {Daniel L} and Bernstein, {Richard A.} and Hage, {Ziad A.} and Batjer, {H. Hunt} and Bendok, {Bernard R.}",
year = "2009",
month = "5",
day = "1",
doi = "10.1016/j.surneu.2007.11.021",
language = "English (US)",
volume = "71",
pages = "604--609",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Symptomatic spontaneous intracranial carotid artery dissection treated with a self-expanding intracranial nitinol stent

T2 - a case report

AU - Surdell, Daniel L

AU - Bernstein, Richard A.

AU - Hage, Ziad A.

AU - Batjer, H. Hunt

AU - Bendok, Bernard R.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Background: Although extracranial carotid dissection with stroke is common, intracranial dissection with stroke is rare. Stenting has been used to treat extracranial carotid dissections. Intracranially, however, it is only recently that stents have become a feasible option for this disease. We present a case of a spontaneous intracranial CAD with progressive symptoms despite medical management treated with a self-expanding intracranial micronitinol stent. Case Description: A 47-year-old, right-handed woman presented to the emergency department after noticing left-sided face and arm weakness and numbness, along with slurred speech. The patient was started on aspirin 325 mg/d orally and lovenox 40 mg/d subcutaneously. On hospital day 2, the patient was noted to have repeated episodes of weakness and numbness on the left side and MRI evidence of a new stroke. A diagnostic cerebral angiogram from a selective right internal carotid injection revealed a flow-limiting stenosis secondary to a dissection of the supraclinoid internal carotid artery with severe flow limitation to the hemisphere. Endovascular management was decided on, and a Neuroform stent measuring 4.5 × 20 mm (Boston Scientific Corporation, Natick, Mass) was deployed across the dissection with significant improvement of flow to that hemisphere on the poststent angiogram. Conclusions: This case illustrates the successful off-label use of a self-expanding intracranial nitinol stent to treat a symptomatic intracranial internal CAD in the setting of failure of traditional medical management. This is a promising application of novel endovascular technology.

AB - Background: Although extracranial carotid dissection with stroke is common, intracranial dissection with stroke is rare. Stenting has been used to treat extracranial carotid dissections. Intracranially, however, it is only recently that stents have become a feasible option for this disease. We present a case of a spontaneous intracranial CAD with progressive symptoms despite medical management treated with a self-expanding intracranial micronitinol stent. Case Description: A 47-year-old, right-handed woman presented to the emergency department after noticing left-sided face and arm weakness and numbness, along with slurred speech. The patient was started on aspirin 325 mg/d orally and lovenox 40 mg/d subcutaneously. On hospital day 2, the patient was noted to have repeated episodes of weakness and numbness on the left side and MRI evidence of a new stroke. A diagnostic cerebral angiogram from a selective right internal carotid injection revealed a flow-limiting stenosis secondary to a dissection of the supraclinoid internal carotid artery with severe flow limitation to the hemisphere. Endovascular management was decided on, and a Neuroform stent measuring 4.5 × 20 mm (Boston Scientific Corporation, Natick, Mass) was deployed across the dissection with significant improvement of flow to that hemisphere on the poststent angiogram. Conclusions: This case illustrates the successful off-label use of a self-expanding intracranial nitinol stent to treat a symptomatic intracranial internal CAD in the setting of failure of traditional medical management. This is a promising application of novel endovascular technology.

KW - Intracranial dissection

KW - Intracranial stent

KW - Spontaneous dissection

UR - http://www.scopus.com/inward/record.url?scp=64649096450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64649096450&partnerID=8YFLogxK

U2 - 10.1016/j.surneu.2007.11.021

DO - 10.1016/j.surneu.2007.11.021

M3 - Article

VL - 71

SP - 604

EP - 609

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - 5

ER -